May 5 (Reuters) - Vertex Pharmaceuticals (VRTX.O), opens new tab missed Wall Street estimates for quarterly results on Monday due to lower-than-expected sales of its cystic fibrosis (CF) drug Trikafta ...
Editor’s note: This story originates in the Lede, a daily curated news product for local readers. For more information, visit https://www.alabamalede.com. On Friday, Vertex Energy, an oil company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback